Inflammatory rebound and postinfectious inflammatory response in children with pleural infection: A single-center retrospective study
- PMID: 38206078
- DOI: 10.1002/ppul.26859
Inflammatory rebound and postinfectious inflammatory response in children with pleural infection: A single-center retrospective study
Abstract
Introduction: As pleural inflammation plays a central role in pleural infection (PI), corticosteroids are increasingly being considered as a potential therapy. However, the timing of treatment and the identification of patients who might benefit most remain unresolved. The aim of this study was therefore to investigate the inflammatory trajectories of children with PI.
Methods: This retrospective single-center study included children aged 3 months to 17 years and 11 months hospitalized for PI due to Streptococcus pyogenes, Streptococcus pneumonia, and Staphylococcus aureus over 10 years. An inflammatory rebound was defined biologically as a reincrease in C-reactive protein (CRP) of at least 50 mg/L after an initial decrease in CRP of at least 50 mg/L.
Results: We included 53 cases of PI, including 16 due to S. pyogenes, 27 due to S. pneumonia, and 10 due to S. aureus. An inflammatory rebound occurred in 20 patients (38%) after a median of 4.5 (3-6) days. This inflammatory rebound occurred in 9 (56%) children with S. pyogenes, 8 (30%) children with S. pneumonia, and 3 (30%) children with S. aureus. Children with an inflammatory rebound also had a higher rate of persistent fever after Day 7 and a longer length of stay (p = .01 for both).
Conclusion: We postulate that the inflammatory rebound identified in nearly 40% of our patients corresponds to an early postinfectious inflammatory response, and thus that corticosteroids may be most beneficial for children with PI if administered early (between Days 2 and 5).
Keywords: corticosteroids; empyema; group A streptococcus; inflammation; mixed effect models; pediatrics.
© 2024 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.
References
REFERENCES
-
- Roberts ME, Rahman NM, Maskell NA, et al. British Thoracic Society Guideline for pleural disease. Thorax. 2023;78(suppl 3):s1‐s42.
-
- The BTS Pleural Guideline Development Group. BTS guideline for pleural disease—draft for public consultation. 2022. Accessed July 2, 2023. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=w...
-
- Light RW. Parapneumonic effusions and empyema. Proc Am Thorac Soc. 2006;3(1):75‐80.
-
- Hafen GM, Grenzbach A‐C, Moeller A, Rochat MK. Lack of concordance in parapneumonic effusion management in children in central Europe. Pediatr Pulmonol. 2016;51(4):411‐417.
-
- Lohuis SJ, de Groot E, Kamps AWA, Ottink MD, de Vries TW, Bekhof J. Conservative treatment of parapneumonic effusion in children: experience from a 10‐year consecutive case series. Pediatr Infect Dis J. 2023;42(3):180‐183.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous